Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vor Biopharma Inc.

    NASDAQ: VOR · Real-Time Price · USD
    2.20
    0.15 (7.32%)
    At close: Aug 20, 2025, 10:04 AM

    Vor Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 81.95M 31.36M 57.71M 119.8M
    Short-Term Investments
    		 9.98M 105.81M 172.54M 87.67M
    Long-Term Investments
    		 n/a 2.41M 2.41M 2.41M
    Other Long-Term Assets
    		 4.8M 4.81M 2.92M 3.25M
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 380K 475K 2.34M 2.09M
    Total Current Assets
    		 96.51M 140.8M 236.95M 214.4M
    Property-Plant & Equipment
    		 41.59M 50.1M 57.08M 22.52M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 46.38M 57.32M 62.42M 28.19M
    Total Assets
    		 142.89M 198.13M 299.37M 242.59M
    Account Payables
    		 1.5M 815K 1.77M 1.54M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a 1.84M
    Other Current Liabilities
    		 n/a 6.29M 4.95M 752K
    Total Current Liabilities
    		 18.61M 15.57M 13.12M 10.15M
    Long-Term Debt
    		 n/a 31.83M n/a 16.17M
    Other Long-Term Liabilities
    		 n/a -31.83M n/a -16.17M
    Total Long-Term Liabilities
    		 27.61M 31.83M 35.64M 16.17M
    Total Liabilities
    		 46.23M 47.4M 48.76M 26.33M
    Total Debt
    		 31.83M 35.66M 38.91M 18.01M
    Common Stock
    		 13K 7K 7K 4K
    Retained Earnings
    		 -456.99M -340.08M -222.22M -130.12M
    Comprehensive Income
    		 22K -77K -770K -242.59M
    Shareholders Equity
    		 96.66M 150.72M 250.61M 216.26M
    Total Investments
    		 9.98M 105.81M 172.54M 87.67M

    Add to Watchlist